Madrigal is focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH). The Senior Director will serve as the company’s subject-matter expert on U.S. GAAP and SEC reporting requirements. The role includes overseeing financial results consolidation and ensuring compliance with financial reporting standards.
Base: $245,000 - $299,000 per year; Bonus/Equity: Not specified; Benefits: Comprehensive benefits including flexible paid time off
Must-have
Nice-to-have
Not specified